Skip to content
Recall Observatory FDA recall evidence

Device product

E25Bio COVID-19 Direct Antigen Rapid Test ; E25Bio COVID-19 DART Kit

Z-0564-2022

January 27, 2022

Class I

Product summary

Firm
E25Bio, Inc.
Event
Event 89485
Status
Terminated
Classification
Class I
Quantity
73,300 units
Official record key
device-enforcement:Z-0564-2022

Official wording

Reason: The Test is not authorized, cleared, or approved by FDA for clinical diagnostic or screening purposes. It was distributed without sufficient directions or controls in place.

Code information: Lot numbers are unavailable. The following Purchase Orders and Dates are affected: Purchase Order/Invoice Number Date 1006 10/13/2020 1007 11/13/2020 1008 11/25/2020 1009 12/18/2020 1010 01/07/2021 1011 01/07/2021 1012 01/07/2021 1011 01/07/2021 1015 1/29/2021 1016 02/03/2021 1019 2/26/2021 1017 2/23/2021 1021 3/05/2021 1023 3/19/2021 1027 04/05/2021 1039 11/03/2021 1040 11/03/2021 1028 4/16/2021 1029 5/10/2021 1032 09/03/2021 1073 11/27/2020

Distribution pattern: US Nationwide distribution in the states of MA, FL, and HI.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    The Test is not authorized, cleared, or approved by FDA for clinical diagnostic or screening purposes. It was distributed without sufficient directions or controls in place.

Field note

Send feedback

We'll only use this to respond to your feedback.